Haploid Allogeneic Transplant Using the CliniMACS System

Stopped This study was superseded by the subsequent study IRB-15919 (NCT01050764)

Conditions

• Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors
• Chronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic Phase
• Myelodysplastic Syndrome (MDS) - High and Intermediate Risk
• Non-Hodgkin's Lymphoma (NHL)
• Chronic Lymphocytic Leukemia (CLL) - Refractory

Interventions

• DEVICE: CliniMACS System

Sponsor

Ginna Laport